4.4 Article

Vascular invasion in hepatocellular carcinoma: is there a correlation with MRI?

Journal

BRITISH JOURNAL OF RADIOLOGY
Volume 85, Issue 1014, Pages 736-744

Publisher

BRITISH INST RADIOLOGY
DOI: 10.1259/bjr/94924398

Keywords

-

Funding

  1. NIHR Cambridge Biomedical Research Centre

Ask authors/readers for more resources

Objective: Hepatocellular carcinoma (HCC) is one of the commonest malignancies worldwide. Prognosis is predicted by size at diagnosis, vascular invasion and tumour proliferation markers. This study investigates if MRI features of histologically proven HCCs correlate with vascular invasion. Methods: Between 2006 and 2008, 18 consecutive patients, with a total of 27 HCCs, had comprehensive MRI studies performed at our institution within a median of 36 days of histology sampling. Each lesion was evaluated independently on MRI by 3 radiologists (blinded to both the radiology and histopathology reports) using a 5-point confidence scale for 23 specific imaging features. The mean of the rating scores across readers was calculated to determine interobserver consistency. The most consistent features were then used to examine the value of features in predicting vascular invasion, using a chi(2) test for trend, having eliminated those features without sufficient variability. Results: 22 of the 23 imaging features showed sufficient variability across lesions. None of these significantly correlated with the presence of vascular invasion, although a trend was identified with the presence of washout in the portal venous phase on MRI and the median size of lesions, which was greater with vascular invasion. Conclusion: This study suggests that no single MRI feature accurately predicts the presence of vascular invasion in HCCs, although a trend was seen with the presence of washout in the portal venous phase post gadolinium. Larger prospective studies are required to investigate this further.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Correction Economics

Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study (Apr, 10.1007/s40273-021-01026-5, 2021)

Becky Pennington, Abualbishr Alshreef, Laura Flight, Andrew Metry, Edith Poku, Philip Hykin, Sobha Sivaprasad, A. Toby Prevost, Joana C. Vasconcelos, Caroline Murphy, Joanna Kelly, Yit Yang, Andrew Lotery, Michael Williams, John Brazier

PHARMACOECONOMICS (2021)

Article Respiratory System

Effect of CRTH2 antagonism on the response to experimental rhinovirus infection in asthma: a pilot randomised controlled trial

Hugo Farne, Nicholas Glanville, Nicholas Johnson, Tata Kebadze, Julia Aniscenko, Eteri Regis, Jie Zhu, Maria-Belen Trujillo-Torralbo, Onn Min Kon, Patrick Mallia, A. Toby Prevost, Michael R. Edwards, Sebastian L. Johnston, Aran Singanayagam, David Joshua Jackson

Summary: The study showed that timapiprant treatment did not attenuate or prevent asthma exacerbations induced by experimental rhinovirus infection in partially controlled asthma patients. However, in bronchial biopsies, the increase in CRTH2 staining during RV-A16 infection was lower in the timapiprant-treated group compared to the placebo-treated group.

THORAX (2022)

Article Health Care Sciences & Services

Adjusting for verification bias in diagnostic accuracy measures when comparing multiple screening tests-an application to the IP1-PROSTAGRAM study

Emily Day, David Eldred-Evans, A. Toby Prevost, Hashim U. Ahmed, Francesca Fiorentino

Summary: This study introduces statistical methods to adjust for verification bias in the accuracy estimates of screening tests. The Begg and Greenes method and multiple imputation are compared to complete case analysis. The results show that both methods increase specificity estimates significantly, while sensitivity estimates remain similar. Negative predictive value (NPV) estimates are higher when adjusting for verification bias, compared to complete case analysis. Positive predictive value (PPV) estimates are similar across all methods.

BMC MEDICAL RESEARCH METHODOLOGY (2022)

Article Ophthalmology

Developing and validating a multivariable prediction model which predicts progression of intermediate to late age-related macular degeneration-the PINNACLE trial protocol

Janice Sutton, Martin J. Menten, Sophie Riedl, Hvroje Bogunovic, Oliver Leingang, Philipp Anders, Ahmed M. Hagag, Sebastian Waldstein, Amber Wilson, Angela J. Cree, Ghislaine Traber, Lars G. Fritsche, Hendrik Scholl, Daniel Rueckert, Ursula Schmidt-Erfurth, Sobha Sivaprasad, Toby Prevost, Andrew Lotery

Summary: This study aims to utilize machine learning and advanced statistical modeling to discover biomarkers for disease progression in intermediate age-related macular degeneration (AMD) and report the natural history of its progression through multimodal retinal imaging.
Article Geriatrics & Gerontology

Mortality of Care Home Residents and Community-Dwelling Controls During the COVID-19 Pandemic in 2020: Matched Cohort Study

Martin C. Gulliford, A. Toby Prevost, Andrew Clegg, Emma Rezel-Potts

Summary: This study estimated and compared the mortality of care home residents and matched community-dwelling controls during the COVID-19 pandemic in England using primary care electronic health records. The results showed that care home residents had a significantly higher mortality rate than the community-dwelling controls, with a disproportionate increase during the first wave of the pandemic. Therefore, care home residents need special protection during periods of high infectious disease transmission.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2022)

Article Medicine, Research & Experimental

The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recent HIV infection-study protocol for a two-stage randomised phase II trial

Ming Jie Lee, Simon Collins, Daphne Babalis, Nicholas Johnson, Emanuela Falaschetti, A. Toby Prevost, Ambreen Ashraf, Milaana Jacob, Tom Cole, Lisa Hurley, Matthew Pace, Ane Ogbe, Maryam Khan, Panagiota Zacharopoulou, Helen Brown, Euan Sutherland, Hanna Box, Julie Fox, Steven Deeks, Jill Horowitz, Michel C. Nussenzweig, Marina Caskey, John Frater, Sarah Fidler

Summary: This study aims to evaluate the effectiveness of two long-acting broadly neutralising antibodies as a treatment for HIV. The study will conduct a randomized placebo-controlled trial, with participants receiving different treatment regimens. The primary endpoint is the time to viral rebound during treatment interruptions. Secondary and exploratory endpoints include adverse events and immunological markers.

TRIALS (2022)

Article Endocrinology & Metabolism

Burden of undiagnosed and suboptimally controlled diabetes in selected regions of India: Results from the SMART India population-level diabetes screening study

Ramachandran C. Rajalakshmi, Joana Vasconcelos, A. Toby Prevost, Sobha Sivaprasad, Mohan Deepa, Rajiv Raman, Kim Ramasamy, Ranjit Mohan Anjana, Dolores Conroy, Taraprasad Das, Wasim Hanif, Viswanathan Mohan

Summary: This study aimed to estimate the prevalence of undiagnosed and suboptimally controlled diabetes in India and identify the associated risk factors. The findings revealed a high prevalence of undiagnosed diabetes (6.0%) and suboptimally controlled diabetes. These results emphasize the urgent need to identify and optimize treatment for individuals with diabetes to reduce the burden of the disease.

DIABETIC MEDICINE (2023)

Article Primary Health Care

Spirometry services in England post-pandemic and the potential role of AI support software: a qualitative study of challenges and opportunities

Gillian Doe, Stephanie J. C. Taylor, Marko Topalovic, Richard Russell, Rachael A. Evans, Julie Maes, Karolien Van Orshovon, Anthony Sunjaya, David Scott, A. Toby Prevost, Ethaar El-Emir, Jennifer Harvey, Nicholas S. Hopkinson, Samantha S. Kon, Suhani Patel, Ian Jarrold, Nanette Spain, William D-C Man, Ann Hutchinson

Summary: This study aimed to explore perspectives on spirometry provision in primary care and the potential for artificial intelligence (AI) decision support software to improve quality and interpretation. The study found historical challenges and the impact of the pandemic on inequity in spirometry provision. It suggests delivering services closer to patients’ homes by appropriately trained staff and highlights the potential role of AI in supporting clinicians. However, sufficient validation of the software is crucial for clinician and healthcare commissioner trust in the process.

BRITISH JOURNAL OF GENERAL PRACTICE (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Development and Evaluation of Machine Learning in Whole-Body Magnetic Resonance Imaging for Detecting Metastases in Patients With Lung or Colon Cancer

Andrea G. Rockall, Xingfeng Li, Nicholas Johnson, Ioannis Lavdas, Shalini Santhakumaran, A. Toby Prevost, Shonit Punwani, Vicky Goh, Tara D. Barwick, Nishat Bharwani, Amandeep Sandhu, Harbir Sidhu, Andrew Plumb, James Burn, Aisling Fagan, Georg J. Wengert, Dow-Mu Koh, Krystyna Reczko, Qi Dou, Jane Warwick, Xinxue Liu, Christina Messiou, Nina Tunariu, Peter Boavida, Neil Soneji, Edward W. Johnston, Christian Kelly-Morland, Katja N. De Paepe, Heminder Sokhi, Kathryn Wallitt, Amish Lakhani, James Russell, Miriam Salib, Sarah Vinnicombe, Adam Haq, Eric O. Aboagye, Stuart Taylor, Ben Glocker

Summary: The study aimed to develop a machine learning algorithm to improve radiologists' sensitivity and specificity for metastasis detection in whole-body magnetic resonance imaging (WB-MRI). The results showed that using the algorithm can enhance the detection accuracy and reduce reading times for radiologists.

INVESTIGATIVE RADIOLOGY (2023)

Article Substance Abuse

An Automated, Online Feasibility Randomized Controlled Trial of a Just-In-Time Adaptive Intervention for Smoking Cessation (Quit Sense)

Felix Naughton, Aimie Hope, Chloe Siegele-Brown, Kelly Grant, Garry Barton, Caitlin Notley, Cecilia Mascolo, Tim Coleman, Lee Shepstone, Stephen Sutton, A. Toby Prevost, David Crane, Felix Greaves, Juliet High

Summary: This study aimed to evaluate the feasibility and effectiveness of the Quit Sense smartphone app, which helps smokers identify smoking cues and provides real-time support for quitting. The results showed that participants using Quit Sense had a sustained abstinence rate of 11.5% at 6 months, compared to 2.9% for those using usual care. The findings suggest that Quit Sense may be an effective smoking cessation tool.

NICOTINE & TOBACCO RESEARCH (2023)

Article Health Care Sciences & Services

Integrated Short-term Palliative Rehabilitation to improve quality of life and equitable care access in incurable cancer (INSPIRE): a multinational European research project

Joanne Bayly, Hilde Hjelmeland Ahmedzai, Maria Grazia Blandini, Barbara Bressi, Augusto Tommaso Caraceni, Joana Carvalho Vasconcelos, Stefania Costi, Stefania Fugazzaro, Monica Guberti, Mai-Britt Guldin, May Hauken, Irene Higginson, Barry J. A. Laird, Julie Ling, Charles Normand, Lise Nottelmann, Line Oldervoll, Cathy Payne, A. Toby Prevost, Guro B. Stene, Elisa Vanzulli, Eduardo Veber, Guillaume Economos, Matthew Maddocks

Summary: This multinational trial aims to test the clinical and cost-effectiveness of a short-term palliative rehabilitation intervention for people with incurable cancer. Through comparative analysis, mixed-method evaluation, evidence synthesis, and Delphi consensus, the trial will contribute to the development of an international framework for palliative rehabilitation practice and policy.

PALLIATIVE CARE & SOCIAL PRACTICE (2023)

Article Medicine, General & Internal

Development and validation of predictive risk models for sight threatening diabetic retinopathy in patients with type 2 diabetes to be applied as triage tools in resource limited settings

Manjula D. Nugawela, Sarega Gurudas, A. Toby Prevost, Rohini Mathur, John Robson, Thirunavukkarasu Sathish, J. M. Rafferty, Ramachandran Rajalakshmi, Ranjit Mohan Anjana, Saravanan Jebarani, Viswanathan Mohan, David R. Owens, Sobha Sivaprasad

Summary: This study aimed to develop and validate predictive models for sight threatening diabetic retinopathy (STDR) to identify high-risk population for retinal screening among people with Type 2 diabetes. The models were developed using datasets from general practices in inner London, UK and externally validated in cohorts from Wales, UK and India. The results showed that the developed models had good performance in predicting STDR.

ECLINICALMEDICINE (2022)

Article Rheumatology

Characterization of missing data patterns and mechanisms in longitudinal composite outcome trial in rheumatoid arthritis

Fowzia Ibrahim, Brian D. M. Tom, David L. Scott, Andrew Toby Prevost

Summary: This study analyzed missing data patterns and mechanisms in a rheumatoid arthritis trial, and proposed the best approach to handle missingness in composite outcomes. The impact on treatment estimates in patients who only provide data at milestone assessments was also assessed.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2022)

Article Ophthalmology

Multicenter Evaluation of Diagnostic Circulating Biomarkers to Detect Sight-Threatening Diabetic Retinopathy

Sarega Gurudas, Karen Frudd, Jayapal Jeya Maheshwari, Yeddula Rebecca Revathy, Sobha Sivaprasad, Shruthi Mahalakshmi Ramanathan, Vignesh Pooleeswaran, A. Toby Prevost, Eleni Karatsai, Sandra Halim, Shruti Chandra, Paul Nderitu, Dolores Conroy, Subramanian Krishnakumar, Sowmya Parameswaran, Kuppamuthu Dharmalingam, Kim Ramasamy, Rajiv Raman, Colin Jones, Haralabos Eleftheriadis, John Greenwood, Patric Turowski

Summary: Serum cystatin C can be considered as a marker for prioritizing retinal screening for diabetic retinopathy.

JAMA OPHTHALMOLOGY (2022)

Article Endocrinology & Metabolism

Improving the Interpretation of Afternoon Cortisol Levels and SSTs to Prevent Misdiagnosis of Adrenal Insufficiency

Vijay Ramadoss, Katharine Lazarus, Andrew Toby Prevost, Tricia Tan, Karim Meeran, Sirazum Choudhury

Summary: Afternoon cortisol >234 nmol/L on Abbott analyser platforms can exclude adrenal insufficiency, while including both 30- and 60-min SST cortisol values in patients with afternoon cortisol <234 nmol/L can prevent unnecessary glucocorticoid replacement therapy in 22.3% of individuals in this study. The SST cortisol cutoffs used on Abbott analyser platforms to define adrenal insufficiency should be 366.5 nmol/L and 418.5 nmol/L at 30 and 60 min, respectively. All patients remained well subsequently with at least 1-year longitudinal follow-up.

JOURNAL OF THE ENDOCRINE SOCIETY (2021)

No Data Available